Source: Registered Drug Product Database (NG) Publisher: Marketed in Nigeria by: Geneith Pharm. Limited, 12 Adewale Crescent, Off Oshodi-Apape Exp. Way, Oshodi, Lagos-Nigeria Manufactured by: M/s Innova Captab Ltd., 81-B, EPIP, Phase-I, Jharmajri, Baddi-173205, Distt. Solan, HP
Larykul Forte is indicated for the treatment of Neuropathic pain, Adjunct in partial seizures, Fibromyalgia, Anxiety.
Oral.
Initially, 150 mg/day, may increase in increments of 150 mg wkly.
Max: 600 mg/day.
All doses to be given in 2 or 3 divided doses.
Haemodialysis: 25-100 mg immediately after each 4-hr haemodialysis session.
| CrCl (ml/min) | Dosage Recommendation |
|---|---|
| 30 to <60 | 75 mg/day. Max: 300 mg/day. All doses to be given in 2 or 3 divided doses. |
| 15 to <30 | Initially, 25-50 mg/day. Max: 150 mg/day. All doses to be given as a single dose or in 2 divided doses. |
| <15 | Initially, 25 mg/day. Max: 75 mg/day. All doses to be given as a single dose. |
Symptoms: Somnolence, agitation, restlessness, confusional state or coma.
Management: Symptomatic and supportive treatment. May be removed by haemodialysis.
24 months.
Store in dry place below 30°C. Protect from light.
Keep out of reach of children.
3 x 10 Alu-Alu Blister Packing.
No special requirements for disposal.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.